OGINasdaqPharmaceutical PreparationsFiscal year ends September 30

ORGANIGRAM GLOBAL INC.

Financials through fiscal 2022, year ended Aug 31, 2022Last filing: 40-F on Dec 16, 2025

$0.94+0.02 (+1.73%)

Close on Oct 19, 2026

Community

Notes and questions about Organigram Global from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Organigram Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Dec 19, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is OGI.

Revenue growth84.2% · median 15.8%

Gross margin21.7% · median 25.2%

Operating margin-29.6% · median -170.1%

Advertisement
300 × 250